Last reviewed · How we verify

NCT03312660

Effect of a Kefir Beverage on Immunity and Lipid Profile

Completed NA Last updated 5 March 2018
What this trial tests

NA trial testing Prebiotic group in Prebiotics in 158 participants. Completed in 27 November 2017.

Timeline
10 April 2017
Primary endpoint
23 November 2017
27 November 2017

Quick facts

Lead sponsorHospital Clinico Universitario de Santiago
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment158
Start date10 April 2017
Primary completion23 November 2017
Estimated completion27 November 2017
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Clinico Universitario de Santiago

Who can join

Adults 3 to 85, any sex, with Prebiotics. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an exploratory cluster randomized controlled trial to evaluate the effect of a kefir beverage, enriched with prebiotics components, on immunity, lipid profile and adiposity in a population-based study, using the family as the intervention unit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Prebiotic group

Trials testing the same drug.

Other recruiting trials for Prebiotics

Currently open trials in the same condition.

Other Hospital Clinico Universitario de Santiago trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03312660.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing